相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis
Tuo Liang et al.
BMC IMMUNOLOGY (2022)
Naringin promotes osteogenesis and ameliorates osteoporosis development by targeting JAK2/STAT3 signalling
Wang Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)
Drug discovery in spinal cord injury-induced osteoporosis: a text mining-based study
Chenfeng Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
Allan L. Klein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Genetic Scores of eNOS, ACE and VEGFA Genes Are Predictive of Endothelial Dysfunction Associated Osteoporosis in Postmenopausal Women
Puneetpal Singh et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
Pim Aarts et al.
DRUGS (2021)
Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the HGF/PTEN/Wnt/β-catenin axis
Jun Zhang et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)
Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases
Lingxin Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
An open-source drug discovery platform enables ultra-large virtual screens
Christoph Gorgulla et al.
NATURE (2020)
Macrophage Polarization and Osteoporosis: A Review
Joseph Munoz et al.
NUTRIENTS (2020)
Punicalagin Exerts Protective Effects against Ankylosing Spondylitis by Regulating NF-κB-TH17/JAK2/STAT3 Signaling and Oxidative Stress
Xinzhe Feng et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
Irene Llorente et al.
FRONTIERS IN MEDICINE (2020)
Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
Hyung Joon Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis
Yanan An et al.
FASEB JOURNAL (2019)
Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
L. Torres et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
Danielle Harmer et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
Daniel V. T. Catenacci et al.
LANCET ONCOLOGY (2017)
Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis
Nasser M. Al-Daghri et al.
MEDICINE (2017)
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
Tsung-Rong Kuo et al.
BIOMARKER RESEARCH (2017)
Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis
Peng Liu et al.
CELL DEATH AND DIFFERENTIATION (2017)
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
J. Zhou et al.
OSTEOPOROSIS INTERNATIONAL (2016)
The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis
Jian-Cheng Xi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Irene Brana et al.
TARGETED ONCOLOGY (2015)
Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis
Eva Klingberg et al.
JOURNAL OF RHEUMATOLOGY (2014)
Bisphosphonates vs infliximab in ankylosing spondylitis treatment
Ombretta Viapiana et al.
RHEUMATOLOGY (2014)
Effects of geraniin on osteoclastic bone resorption and matrix metalloproteinase-9 expression
Bo He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The emerging role of MET/HGF inhibitors in oncology
Giorgio V. Scagliotti et al.
CANCER TREATMENT REVIEWS (2013)
Osteoporosis and vertebral fractures in ankylosing spondylitis
Nicole Davey-Ranasinghe et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
Jong-Ho Lee et al.
CANCER RESEARCH (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
Osteoporosis: A Paradox in Ankylosing Spondylitis
Shea Carter et al.
Current Osteoporosis Reports (2011)
Osteoporosis in Ankylosing Spondylitis
Marina Magrey et al.
Current Rheumatology Reports (2010)
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
S. Visvanathan et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis
A. Bal et al.
CLINICAL RHEUMATOLOGY (2007)
分享论文
